GALDERMA LABS LP FDA Approval NDA 021535

NDA 021535

GALDERMA LABS LP

FDA Drug Application

Application #021535

Documents

Letter2012-12-03
Label2003-07-28
Label2012-08-20
Label2014-01-14
Review2004-06-14
Letter2003-07-28
Letter2012-08-20

Application Sponsors

NDA 021535GALDERMA LABS LP

Marketing Status

Prescription001

Application Products

001LOTION;TOPICAL0.05%1CLOBEXCLOBETASOL PROPIONATE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2003-07-24STANDARD
LABELING; LabelingSUPPL2AP2012-08-17UNKNOWN
LABELING; LabelingSUPPL3AP2012-11-30UNKNOWN

Submissions Property Types

ORIG1Null31
SUPPL2Null6
SUPPL3Null6

TE Codes

001PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21535
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.